Levothyroxine Sodium combined with Ventolin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Renal Failure Acute Death 79 Female 2/13/2006 Canada
Primary
Concomitant
Surgery Hospitalization 67 Female 2/27/2006 Consumer Canada
Primary
Concomitant
Gastric Operation Hospitalization 67 Female 4/5/2006 Consumer Canada
Primary
Concomitant
Renal Failure Acute Death 1/1/1999 79 Female 4/19/2006 Canada
Primary
Concomitant
Prothrombin Time Prolonged 10/20/2005 80 Female 150 lb 4/6/2006 Physician United States
Primary
Concomitant
Pleuritic Pain Hospitalization 3/11/2005 57 Female 173 lb 6/9/2006 Physician Canada
Primary
Concomitant
Pain In Extremity Other Serious 6/6/2006 65 Female 8/21/2006 Pharmacist United Kingdom
Primary
Concomitant
Injection Site Abscess Hospitalization 45 Female 10/23/2006 Consumer United Kingdom
Primary
Concomitant
Vomiting Hospitalization 3/20/2006 56 Female 143 lb 11/20/2006 Physician Belgium
Primary
Concomitant
Vision Blurred Disability 7/1/2006 57 Female 12/5/2006 United Kingdom
Primary
Concomitant
Weight Increased Other Serious 9/1/2002 42 Female 2/5/2007 Physician France
Primary
Secondary
Concomitant
Bradycardia Hospitalization 10/8/2006 28 Female 2/12/2007 Consumer Australia
Primary
Secondary
Concomitant
Peak Expiratory Flow Rate Increased Other Serious 57 Female 3/26/2007 United States
Primary
Secondary
Concomitant
Urinary Bladder Polyp Required Intervention 12/1/2004 81 Female 160 lb 4/6/2007 Physician United States
Primary
Concomitant
Hypotension Hospitalization 11/5/2006 Male 4/30/2007 Physician Australia
Primary
Secondary
Concomitant
Vertigo Other Serious 12/1/2006 82 Female 5/1/2007 Other Health Professional United Kingdom
Primary
Concomitant
Swollen Tongue Other Serious 37 Female 331 lb 5/10/2007 Consumer United Kingdom
Primary
Secondary
Concomitant
Vertigo Other Serious 12/1/2006 82 Female 5/11/2007 Other Health Professional United Kingdom
Primary
Concomitant
Hypotension Hospitalization 11/5/2006 Male 5/18/2007 Physician Australia
Primary
Secondary
Concomitant
Hypotension Hospitalization 11/5/2006 Male 5/29/2007 Physician Australia
Primary
Secondary
Concomitant
Weight Increased Other Serious 9/1/2002 42 Female 6/13/2007 Physician France
Primary
Secondary
Concomitant
Respiratory Failure Death 4/1/2007 78 Female 6/12/2007 Physician France
Primary
Concomitant
Respiratory Failure Death 4/1/2007 78 Female 6/12/2007 Physician France
Primary
Concomitant
Vertigo Other Serious 12/1/2006 82 Female 7/16/2007 Other Health Professional United Kingdom
Primary
Concomitant
Death Other Serious Male 185 lb 8/14/2007 Other Health Professional United Kingdom
Primary
Concomitant
Tumour Invasion Other Serious 7/1/2007 63 Female 8/30/2007 Canada
Primary
Concomitant
Respiratory Failure Other Serious 7/1/2007 63 Female 9/13/2007 Canada
Primary
Concomitant
Myocardial Ischaemia Other Serious Male 185 lb 9/21/2007 Other Health Professional United Kingdom
Primary
Concomitant
Oedema Peripheral Other Serious 4/1/2007 Female 9/21/2007 Consumer Australia
Primary
Concomitant
Progesterone Receptor Assay Positive Other Serious 2/8/2007 74 Female 10/8/2007 Physician France
Primary
Concomitant
Bronchiectasis Other Serious 9/1/2007 79 Female 112 lb 11/7/2007 Other Health Professional United Kingdom
Primary
Concomitant
No Therapeutic Response Other Serious 9/1/2007 79 Female 112 lb 11/13/2007 Other Health Professional United Kingdom
Primary
Concomitant
Nausea Hospitalization 2/13/2007 86 Female 11/16/2007 Physician Norway
Primary
Secondary
Concomitant
Bronchiectasis Other Serious 9/1/2007 79 Female 112 lb 11/13/2007 Other Health Professional United Kingdom
Primary
Concomitant
Bronchiectasis Other Serious 9/1/2007 79 Female 11/20/2007 United Kingdom
Primary
Concomitant
Premature Baby Hospitalization Female 6 lb 12/18/2007 Consumer Argentina
Primary
Secondary
Concomitant
Somnolence 8/25/1997 77 Male 201 lb 1/4/2008 Pharmacist Canada
Primary
Concomitant
Nausea Hospitalization 2/13/2007 Female 2/12/2008 Physician
Primary
Secondary
Concomitant
Herpes Zoster Other Serious 12/1/2007 73 Female 161 lb 2/14/2008 Physician United Kingdom
Primary
Secondary
Concomitant
Type Iii Immune Complex Mediated Reaction Other Serious 8/23/2007 Female 4/11/2008 Physician France
Primary
Concomitant
Renal Disorder Hospitalization 12/1/2007 73 Female 4/30/2008 Consumer United Kingdom
Primary
Concomitant
Thermal Burn 5/1/2007 62 Female 5/30/2008 Consumer United States
Primary
Concomitant
Renal Failure Acute Hospitalization 4/1/2008 6/6/2008 Consumer France
Primary
Secondary
Concomitant
Superinfection Hospitalization 4/1/2008 98 Male 5/26/2008 France
Primary
Secondary
Concomitant
Cervix Carcinoma Other Serious Female 204 lb 6/20/2008 Consumer United Kingdom
Primary
Concomitant
Urinary Tract Infection Hospitalization 2/11/2008 Female 126 lb 7/8/2008 United States
Primary
Concomitant
Cervical Dysplasia Hospitalization 5/31/2008 Female 204 lb 7/14/2008 Consumer United Kingdom
Primary
Concomitant
Dyspnoea Other Serious 6/1/2008 73 Female 7/28/2008 Consumer United Kingdom
Primary
Secondary
Concomitant
Death Other Serious Female 154 lb 7/29/2008 Other Health Professional United Kingdom
Primary
Concomitant
Renal Disorder Hospitalization 12/1/2007 73 Female 7/29/2008 Consumer United Kingdom
Primary
Concomitant
Renal Failure Acute Death 1/25/2006 70 Female 8/27/2008 Other Health Professional Norway
Primary
Concomitant
Cerebrovascular Accident Hospitalization 12/26/2006 72 Female 10/6/2008 Consumer United Kingdom
Primary
Secondary
Throat Tightness Other Serious 3/1/2008 66 Female 10/22/2008 Consumer United Kingdom
Primary
Secondary
Tremor Other Serious 10/1/2008 65 Male 11/25/2008 Pharmacist United Kingdom
Primary
Concomitant
Cerebrovascular Accident Hospitalization 12/26/2006 72 Female 12/1/2008 Consumer United Kingdom
Primary
Secondary
Lung Neoplasm Malignant Death 1/1/2008 Male 1/13/2009 Consumer
Primary
Concomitant
Dyspnoea Hospitalization 12/26/2006 72 Female 1/14/2009 Physician United Kingdom
Primary
Secondary
Dyspnoea Hospitalization 12/26/2006 72 Female 1/22/2009 Physician United Kingdom
Primary
Secondary
Inappropriate Schedule Of Drug Administration Hospitalization 12/26/2006 72 Female 1/23/2009 Other Health Professional United Kingdom
Primary
Secondary
Dyspnoea Hospitalization 12/26/2006 72 Female 1/29/2009 Other Health Professional Germany
Primary
Secondary
Dyspnoea Hospitalization 12/26/2006 72 Female 1/28/2009 Other Health Professional United Kingdom
Primary
Secondary
Dyspnoea Hospitalization 12/26/2006 Female 1/27/2009 United Kingdom
Primary
Secondary
Shock Hypoglycaemic Other Serious 6/13/2008 50 Female 2/5/2009 Other Health Professional Sweden
Primary
Secondary
Concomitant
Upper Respiratory Tract Infection Other Serious Female 2/6/2009 Physician Sweden
Primary
Concomitant
Nasopharyngitis Other Serious 5/1/2008 58 Female 2/9/2009 Consumer United Kingdom
Primary
Secondary
Dyspnoea Hospitalization 11/26/2006 72 Female 2/4/2009 Consumer United Kingdom
Primary
Secondary
Dyspnoea Hospitalization 12/26/2006 72 Female 2/23/2009 United Kingdom
Primary
Secondary
Dyspnoea Hospitalization 12/26/2006 72 Female 2/23/2009 United Kingdom
Primary
Secondary
Tremor Hospitalization 73 Female 3/24/2009 Consumer United Kingdom
Primary
Secondary
Concomitant
Middle Insomnia Other Serious 10/1/2008 Female 4/2/2009 Physician United Kingdom
Primary
Secondary
Lower Respiratory Tract Infection Other Serious Female 4/3/2009 Consumer United Kingdom
Primary
Secondary
Throat Irritation Other Serious 12/1/2008 35 Female 4/9/2009 Pharmacist United Kingdom
Primary
Concomitant
Left Ventricular Dysfunction Life Threatening 11/27/2008 Female 4/17/2009 Consumer United Kingdom
Primary
Secondary
Concomitant
Dyspnoea Hospitalization 12/26/2006 72 Female 4/8/2009 United Kingdom
Primary
Secondary
Concomitant
Tracheal Pain Other Serious 3/3/2009 Male 4/20/2009 Pharmacist France
Primary
Secondary
Concomitant
Dyspnoea Hospitalization 12/26/2006 72 Female 4/8/2009 United Kingdom
Primary
Secondary
Lung Neoplasm Malignant Death 1/1/2008 Male 4/23/2009 Consumer
Primary
Concomitant
Cerebrovascular Accident Hospitalization 12/26/2006 72 Female 4/22/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Dyspnoea Hospitalization 12/26/2006 72 Female 4/21/2009 United Kingdom
Primary
Secondary
Dyspnoea Hospitalization 12/26/2006 72 Female 4/21/2009 United Kingdom
Primary
Secondary
Mobility Decreased Other Serious 3/10/2009 76 Female 4/24/2009 United Kingdom
Primary
Concomitant
Dyspnoea Hospitalization 12/26/2006 72 Female 5/1/2009 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Anaphylactic Reaction Life Threatening 4/23/2009 68 Female 209 lb 5/26/2009 Consumer United Kingdom
Primary
Concomitant
Product Quality Issue 4/13/2008 65 Female 5/29/2009 Consumer United States
Primary
Concomitant
Nocturia 1/1/2008 Male 6/23/2009 Consumer
Primary
Concomitant
Vomiting Hospitalization 5/28/2009 Female 6/29/2009 Other Health Professional Sweden
Primary
Concomitant
Vomiting Hospitalization 5/27/2009 Female 7/6/2009 Consumer Norway
Primary
Concomitant
Injection Site Haemorrhage Other Serious 7/6/2009 79 Male 154 lb 7/16/2009 Consumer Australia
Primary
Concomitant
Chronic Lymphocytic Leukaemia Other Serious 4/1/2008 Male 154 lb 7/17/2009 Physician Australia
Primary
Secondary
Concomitant
Injection Site Haemorrhage 7/6/2009 Male 154 lb 7/22/2009 Physician Australia
Primary
Concomitant
Chronic Lymphocytic Leukaemia Other Serious 4/1/2008 Male 154 lb 7/23/2009 Physician Australia
Primary
Concomitant
Tremor Other Serious 7/1/2009 46 Female 7/23/2009 Consumer United States
Primary
Concomitant
Hypocalcaemia Other Serious 2/1/2009 Female 247 lb 7/27/2009 Other Health Professional Australia
Primary
Concomitant
Dyspnoea Hospitalization 1/7/2009 72 Male 7/31/2009 United Kingdom
Primary
Concomitant
Skin Burning Sensation Female 286 lb 8/23/2009 Consumer United States
Primary
Concomitant
Hypocalcaemia Other Serious 2/1/2009 Female 247 lb 8/26/2009 Other Health Professional Australia
Primary
Concomitant
Dyspnoea Hospitalization 12/26/2006 72 Female 9/9/2009 United Kingdom
Primary
Concomitant
Thrombocytopenia Hospitalization Female 176 lb 9/17/2009 Physician France
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/2009 70 Female 119 lb 9/18/2009 Other Health Professional United States
Primary
Concomitant
Hypocalcaemia Other Serious 2/1/2009 Female 247 lb 9/28/2009 Other Health Professional Australia
Primary
Concomitant
Pulmonary Hypertension Hospitalization Female 10/20/2009 Physician United States
Primary
Concomitant
Thrombocytopenia Hospitalization 8/5/2009 Female 176 lb 10/21/2009 Physician France
Primary
Secondary
Concomitant
Cellulitis Hospitalization 8/9/2006 53 Female 143 lb 11/6/2009 Physician United Kingdom
Primary
Secondary
Concomitant
Walking Aid User Other Serious 12/26/2006 72 Female 11/12/2009 Consumer Germany
Primary
Secondary
Myocardial Infarction Death 11/4/2009 Female 98 lb 11/13/2009 Canada
Primary
Secondary
Concomitant
Vomiting Hospitalization 6/5/2009 Female 185 lb 11/16/2009 Physician France
Primary
Concomitant
Chronic Lymphocytic Leukaemia Other Serious 4/1/2008 Male 154 lb 11/19/2009 Physician Australia
Primary
Concomitant
Throat Irritation Other Serious 12/1/2008 Female 12/4/2009 Pharmacist United Kingdom
Primary
Concomitant
Rhabdomyolysis Hospitalization 9/19/2009 73 Female 12/28/2009 Physician Norway
Primary
Secondary
Concomitant
Pulmonary Hypertension Hospitalization 3/1/2009 Female 12/31/2009 Physician Canada
Primary
Concomitant
Vomiting Hospitalization 5/27/2009 Female 1/4/2010 Consumer Norway
Primary
Concomitant
Pulmonary Hypertension Hospitalization 1/1/2009 Female 1/5/2010 Physician Canada
Primary
Concomitant
Myocardial Infarction Death 11/4/2009 Female 98 lb 1/6/2010 Canada
Primary
Secondary
Concomitant
Pulmonary Hypertension Hospitalization 1/1/2009 Female 1/20/2010 Physician Canada
Primary
Concomitant
Type 2 Diabetes Mellitus Other Serious 4/21/2005 65 Female 3/12/2010 Lawyer Norway
Primary
Secondary
Concomitant
Basal Cell Carcinoma Other Serious 69 Male 269 lb 3/17/2010 Physician United States
Primary
Concomitant
Type 2 Diabetes Mellitus Other Serious 4/21/2005 61 Female 3/25/2010 Lawyer Norway
Primary
Secondary
Concomitant
Wheezing Other Serious 4/1/2009 Female 212 lb 3/29/2010 Physician United States
Primary
Concomitant
Respiratory Disorder Other Serious 11/4/2009 Female 212 lb 3/29/2010 Physician United States
Primary
Concomitant
Sinusitis Other Serious 59 Female 5/7/2010 Consumer United States
Primary
Concomitant
Weight Decreased Hospitalization 3/1/2010 77 Female 5/28/2010 Consumer United States
Primary
Concomitant
Wheezing 60 Female 5/28/2010 Consumer United States
Primary
Secondary
Concomitant
Respiratory Tract Irritation 50 Female 5/28/2010 Consumer United States
Primary
Concomitant
Respiratory Disorder Other Serious 11/4/2009 39 Female 212 lb 6/2/2010 Physician United States
Primary
Concomitant
Wheezing Other Serious 4/1/2009 38 Female 212 lb 6/2/2010 Physician United States
Primary
Concomitant
Product Quality Issue Other Serious 5/6/2010 43 Female 6/11/2010 Pharmacist France
Primary
Concomitant
Thrombocytopenia Hospitalization 8/7/2009 59 Female 176 lb 6/16/2010 Pharmacist France
Primary
Secondary
Concomitant
Toxic Epidermal Necrolysis Hospitalization 5/1/2010 76 Female 6/18/2010 Other Health Professional France
Primary
Secondary
Concomitant
Acute Generalised Exanthematous Pustulosis Hospitalization 5/21/2010 51 Female 6/23/2010 Other Health Professional France
Primary
Secondary
Concomitant
Acute Generalised Exanthematous Pustulosis Hospitalization 5/21/2010 51 Female 6/29/2010 Other Health Professional France
Primary
Secondary
Concomitant
Pruritus Hospitalization 5/21/2010 51 Female 6/28/2010 Consumer France
Primary
Secondary
Concomitant
Acute Generalised Exanthematous Pustulosis Hospitalization 5/21/2010 51 Female 6/28/2010 Physician France
Primary
Secondary
Concomitant
Wheezing Other Serious 4/1/2009 38 Female 212 lb 7/1/2010 Physician United States
Primary
Concomitant
Throat Irritation Other Serious 12/1/2008 35 Female 7/6/2010 Pharmacist United Kingdom
Primary
Concomitant
Sinusitis Other Serious 59 Female 7/8/2010 Consumer United States
Primary
Concomitant
Toxic Epidermal Necrolysis Hospitalization 5/1/2010 76 Female 7/9/2010 Other Health Professional France
Primary
Secondary
Concomitant
Product Quality Issue Other Serious 5/6/2010 43 Female 7/28/2010 Pharmacist France
Primary
Concomitant
Pyrexia 1/1/2010 37 Female 7/29/2010 United States
Primary
Concomitant
Hepatic Congestion Hospitalization 7/15/2010 76 Female 110 lb 8/6/2010 Ireland
Primary
Concomitant
Hepatic Congestion Hospitalization 7/15/2010 76 Female 110 lb 8/17/2010 Ireland
Primary
Concomitant
Sedation Hospitalization 89 Female 99 lb 8/24/2010 Physician Australia
Primary
Concomitant
Red Blood Cell Sedimentation Rate Increased Other Serious 6/15/2010 85 Female 161 lb 8/25/2010 Physician Australia
Primary
Concomitant
Throat Tightness Other Serious 63 Female 9/9/2010 Consumer United States
Primary
Concomitant
Overdose Other Serious 77 Male 9/16/2010 Pharmacist France
Primary
Concomitant
Lung Neoplasm Malignant Hospitalization 7/6/2010 79 Female 110 lb 9/20/2010 Other Health Professional Canada
Primary
Concomitant
Wheezing Other Serious 4/1/2009 38 Female 212 lb 10/1/2010 Physician United States
Primary
Concomitant
Thrombocytopenia Other Serious 10/1/2009 50 Male 228 lb 10/5/2010 Physician United States
Primary
Concomitant
Left Ventricular Dysfunction Other Serious 11/27/2008 74 Female 163 lb 10/6/2010 Physician France
Primary
Secondary
Concomitant
Breast Cancer Hospitalization 9/1/2010 51 Female 10/21/2010 Physician France
Primary
Secondary
Concomitant
Wheezing Other Serious 4/1/2009 38 Female 212 lb 10/27/2010 Physician United States
Primary
Concomitant

Drug Data